Obstructive sleep apnea (OSA) in children covers a spectrum of respiratory disorders characterized by upper airway collapse during sleep.
1,2 The pathogenesis of childhood OSA is mainly due to enlarged adenotonsillar tissues.
3-5 Adenotonsillectomy is widely considered the first-line therapy for childhood sleep apnea.
1,6,7 Treatment outcomes for adenotonsillectomy have been studied extensively.
8-12 In 2006, a meta-analysis by Brietzke and Gallagher
8 demonstrated that the mean change in the apnea-hypopnea index (AHI) after adenotonsillectomy was a reduction of 13.92 events per hour, with a success rate of 82.9%. A review article by Friedman et al
9 in 2009 found that the mean change in the AHI after adenotonsillectomy was a reduction of 12.42 events per hour, with an overall success rate lower than commonly believed (59.8% for an AHI<1). A meta-analysis
10 in 2016 by our research group demonstrated that adenotonsillectomy results in notable improvement in a number of sleep variables, with an overall success rate of 51% for a postoperative AHI less than 1. Other meta-analyses
8-10 have shown that postoperative residual OSA remained in approximately half of the children treated with adenotonsillectomy. Therefore, additional treatment strategies are desirable for children with persistent OSA after adenotonsillectomy.
13